1. Home
  2. STXS vs CDLX Comparison

STXS vs CDLX Comparison

Compare STXS & CDLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • CDLX
  • Stock Information
  • Founded
  • STXS 1990
  • CDLX 2008
  • Country
  • STXS United States
  • CDLX United States
  • Employees
  • STXS N/A
  • CDLX N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CDLX Computer Software: Programming Data Processing
  • Sector
  • STXS Health Care
  • CDLX Technology
  • Exchange
  • STXS Nasdaq
  • CDLX Nasdaq
  • Market Cap
  • STXS 151.3M
  • CDLX 98.2M
  • IPO Year
  • STXS 2004
  • CDLX 2018
  • Fundamental
  • Price
  • STXS $2.28
  • CDLX $1.77
  • Analyst Decision
  • STXS
  • CDLX Hold
  • Analyst Count
  • STXS 0
  • CDLX 5
  • Target Price
  • STXS N/A
  • CDLX $3.50
  • AVG Volume (30 Days)
  • STXS 295.9K
  • CDLX 1.3M
  • Earning Date
  • STXS 08-11-2025
  • CDLX 08-06-2025
  • Dividend Yield
  • STXS N/A
  • CDLX N/A
  • EPS Growth
  • STXS N/A
  • CDLX N/A
  • EPS
  • STXS N/A
  • CDLX N/A
  • Revenue
  • STXS $27,510,000.00
  • CDLX $272,588,000.00
  • Revenue This Year
  • STXS $25.90
  • CDLX N/A
  • Revenue Next Year
  • STXS $60.57
  • CDLX $5.51
  • P/E Ratio
  • STXS N/A
  • CDLX N/A
  • Revenue Growth
  • STXS 1.50
  • CDLX N/A
  • 52 Week Low
  • STXS $1.54
  • CDLX $1.22
  • 52 Week High
  • STXS $2.72
  • CDLX $9.48
  • Technical
  • Relative Strength Index (RSI)
  • STXS 54.48
  • CDLX 50.89
  • Support Level
  • STXS $2.12
  • CDLX $1.71
  • Resistance Level
  • STXS $2.36
  • CDLX $1.91
  • Average True Range (ATR)
  • STXS 0.09
  • CDLX 0.16
  • MACD
  • STXS 0.00
  • CDLX 0.01
  • Stochastic Oscillator
  • STXS 64.00
  • CDLX 50.54

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

About CDLX Cardlytics Inc.

Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K. and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.

Share on Social Networks: